ArticleInsights into imaging2026
Primary tumor-derived, multiparametric MRI-based deep learning-radiomics-clinical model for predicting lymph node metastasis in early-stage cervical cancer.
Article in Insights into imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectivesTo develop and validate a primary tumor-derived, multiparametric MRI-based deep learning-radiomics-clinical (DLRC) model for predicting pelvic lymph node metastasis (LNM) in early-stage cervical cancer. MATERIALS AND
methodsThis retrospective five-center study selected 1095 patients (Jan 2020-Dec 2022), divided into training (n = 481), internal validation (n = 204), and external validation (n = 410) cohorts. Radiomics and deep learning (DL) features were extracted from the volumetric segmentations of the primary cervical tumors on three MRI sequences (CE-T1WI, DWI, FS-T2WI). After constructing individual radiomics and DL models, the DLRC model was developed by integrating the radiomics_score, optimal DL model, and significant clinical features. Model performance was evaluated using ROC analysis, calibration curves, and decision curve analysis.
resultsThe DLRC model demonstrated superior predictive performance, achieving AUCs of 0.807 (95% CI: 0.766-0.849) in the training cohort, 0.789 (95% CI: 0.721-0.857) in the internal validation cohort, and 0.807 (95% CI: 0.761-0.853) in the external validation cohort. It significantly outperformed both the radiomics model and the optimal DL model (all p < 0.001) in the external validation cohort. The calibration curves indicated good agreement between predictions and observations. The decision curve analysis showed that the DLRC model provided the highest net clinical benefit across most decision thresholds.
conclusionsThe DLRC model, which integrates tumor-derived multiparametric MRI features with clinical features, represents a robust and generalizable tool for the preoperative prediction of LNM. Its comparable accuracy to standardized radiological assessment and clinical utility shows potential to aid in personalized treatment planning for patients with early-stage cervical cancer. CRITICAL RELEVANCE STATEMENT: The combined model (DLRC) integrating deep learning and radiomics features from the primary tumor with clinical characteristics enables preoperative LNM risk stratification, supporting personalized surgical planning and reducing unnecessary lymphadenectomy. KEY POINTS: Accurate preoperative prediction of lymph node metastasis in early-stage cervical cancer remains a significant clinical challenge. The model integrating deep learning and radiomics features derived from the primary tumor with clinical features achieved robust and generalizable predictive performance. The accuracy of a deep learning-radiomics-clinical nomogram for lymph node metastasis risk stratification in early-stage cervical cancer is comparable to standardized radiological assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.